Overview
Amgen Inc., based in the United States, is a prominent biotechnology firm deeply engaged in the development, manufacture, and marketing of therapeutic products for oncology, nephrology, bone health, cardiovascular disease, and inflammation. The company is renowned for its strategic focus on innovative biological treatments and continuous investment in biotechnological research and development to address complex diseases. Key projects include pioneering work in biosimilar products and targeted cancer therapies, which align with its mission to serve patients by transforming new scientific discoveries into advances in medical treatment. Amgen's strong portfolio of patents and collaborative efforts with other industry leaders underscore its influential role in the biotech sector.
AI+ Ask Fintel’s AI assistant about Amgen Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Amgen Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 578.30 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-22 |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | 0.00 |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 1.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Amgen Inc. is MX$6,005.94. The forecasts range from a low of MX$3,506.92 to a high of MX$7,882.82. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Amgen Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-27 | Argus Research | Buy | Buy | Maintains |
| 2024-06-14 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-05-09 | Mizuho | Neutral | Neutral | Maintains |
| 2024-05-03 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-05-03 | William Blair | Market Perform | Outperform | Upgrade |
| 2024-05-03 | UBS | Neutral | Neutral | Maintains |
| 2024-05-03 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-03 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-05-03 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2024-04-17 | UBS | Neutral | Neutral | Maintains |
| 2024-04-17 | TD Cowen | Buy | Buy | Maintains |
| 2024-04-12 | Truist Securities | Buy | Buy | Reiterate |
| 2024-04-03 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-03-28 | Raymond James | Market Perform | Reiterate | |
| 2024-02-08 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-02-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-07 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-02-01 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-01-29 | UBS | Neutral | Neutral | Maintains |
| 2023-12-21 | Daiwa Capital | Neutral | Buy | Upgrade |
| 2023-12-19 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2023-12-12 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2023-11-29 | Truist Securities | Buy | Buy | Reiterate |
| 2023-11-09 | Deutsche Bank | Hold | Initiate | |
| 2023-11-02 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-11-02 | Truist Securities | Hold | Buy | Upgrade |
| 2023-11-02 | UBS | Neutral | Neutral | Maintains |
| 2023-11-01 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-11-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-10-20 | JP Morgan | Neutral | Neutral | Reiterate |
| 2023-10-20 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-10-17 | Argus Research | Buy | Buy | Maintains |
| 2023-10-17 | Morgan Stanley | Equal-Weight | Reiterate | |
| 2023-10-12 | Jefferies | Buy | Buy | Reiterate |
| 2023-10-11 | Leerink Partners | Market Perform | Outperform | Upgrade |
| 2023-10-11 | B of A Securities | Neutral | Reiterate | |
| 2023-10-09 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-09-18 | Argus Research | Buy | Buy | Maintains |
| 2023-09-06 | HSBC | Buy | Initiate | |
| 2023-09-05 | Truist Securities | Hold | Hold | Reiterate |
| 2023-08-14 | Jefferies | Buy | Buy | Maintains |
| 2023-08-14 | Mizuho | Neutral | Neutral | Maintains |
| 2023-08-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-07-25 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-07-12 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-07-11 | Barclays | Underweight | Underweight | Maintains |
| 2023-06-26 | Argus Research | Buy | Buy | Maintains |
| 2023-05-18 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-05-09 | RBC Capital | Sector Perform | Reiterate | |
| 2023-05-01 | Barclays | Underweight | Maintains | |
| 2023-04-28 | Piper Sandler | Overweight | Maintains | |
| 2023-04-24 | Oppenheimer | Outperform | Maintains | |
| 2023-04-14 | Barclays | Underweight | Maintains | |
| 2023-03-13 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2023-02-13 | Truist Securities | Hold | Maintains | |
| 2023-02-02 | SVB Leerink | Market Perform | Maintains | |
| 2023-02-01 | RBC Capital | Sector Perform | Maintains | |
| 2023-02-01 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-02-01 | BMO Capital | Market Perform | Maintains | |
| 2023-02-01 | Credit Suisse | Underperform | Maintains | |
| 2023-02-01 | Cowen & Co. | Outperform | Maintains | |
| 2023-02-01 | Oppenheimer | Outperform | Maintains | |
| 2023-02-01 | Barclays | Underweight | Maintains | |
| 2023-01-19 | Piper Sandler | Overweight | Maintains | |
| 2023-01-18 | Barclays | Underweight | Maintains | |
| 2023-01-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-12-22 | SVB Leerink | Market Perform | Maintains | |
| 2022-12-13 | Piper Sandler | Overweight | Maintains | |
| 2022-12-06 | Oppenheimer | Outperform | Maintains | |
| 2022-11-18 | Credit Suisse | Underperform | Initiate | |
| 2022-11-04 | RBC Capital | Sector Perform | Maintains | |
| 2022-11-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-11-04 | Piper Sandler | Overweight | Maintains | |
| 2022-10-31 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2022-10-12 | Barclays | Equal-Weight | Maintains | |
| 2022-10-11 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2022-08-09 | Atlantic Equities | Underweight | Maintains | |
| 2022-08-05 | RBC Capital | Sector Perform | Maintains | |
| 2022-08-05 | Piper Sandler | Overweight | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-06-01 | Oppenheimer | Outperform | Maintains | |
| 2022-05-23 | SVB Leerink | Market Perform | Initiate | |
| 2022-05-10 | Mizuho | Neutral | Maintains | |
| 2022-04-28 | RBC Capital | Sector Perform | Maintains | |
| 2022-04-28 | Piper Sandler | Overweight | Maintains | |
| 2022-04-28 | BMO Capital | Market Perform | Maintains | |
| 2022-04-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-12 | Barclays | Equal-Weight | Maintains | |
| 2022-02-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-02-09 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-02-09 | Oppenheimer | Outperform | Maintains | |
| 2022-02-09 | Barclays | Equal-Weight | Maintains | |
| 2022-01-05 | B of A Securities | Buy | Neutral | Downgrade |
| 2021-12-21 | RBC Capital | Sector Perform | Maintains | |
| 2021-12-09 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-12-06 | Goldman Sachs | Buy | Initiate | |
| 2021-11-22 | Mizuho | Neutral | Maintains | |
| 2021-11-19 | BMO Capital | Market Perform | Initiate | |
| 2021-11-03 | RBC Capital | Sector Perform | Maintains | |
| 2021-11-03 | Barclays | Equal-Weight | Maintains | |
| 2021-11-03 | SVB Leerink | Market Perform | Maintains | |
| 2021-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-09-23 | Daiwa Capital | Outperform | Neutral | Downgrade |
| 2021-09-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2021-08-04 | SVB Leerink | Market Perform | Maintains | |
| 2021-07-16 | Morgan Stanley | Overweight | Maintains | |
| 2021-06-07 | SVB Leerink | Market Perform | Maintains | |
| 2021-06-07 | Oppenheimer | Outperform | Maintains | |
| 2021-05-03 | Oppenheimer | Outperform | Maintains | |
| 2021-04-28 | Atlantic Equities | Neutral | Underweight | Downgrade |
| 2021-04-28 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-28 | Credit Suisse | Outperform | Maintains | |
| 2021-04-28 | SVB Leerink | Market Perform | Maintains | |
| 2021-04-28 | RBC Capital | Sector Perform | Maintains | |
| 2021-04-19 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-05 | Oppenheimer | Outperform | Maintains | |
| 2021-03-05 | Barclays | Equal-Weight | Maintains | |
| 2021-03-05 | Morgan Stanley | Overweight | Maintains | |
| 2021-03-05 | SVB Leerink | Market Perform | Maintains | |
| 2021-03-01 | SVB Leerink | Market Perform | Maintains | |
| 2021-02-03 | Cantor Fitzgerald | Overweight | Maintains | |
| 2021-02-03 | Credit Suisse | Outperform | Maintains | |
| 2021-02-03 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-03 | Piper Sandler | Overweight | Maintains | |
| 2021-02-03 | SVB Leerink | Market Perform | Maintains | |
| 2021-01-19 | Morgan Stanley | Overweight | Maintains | |
| 2020-12-16 | Morgan Stanley | Overweight | Maintains | |
| 2020-12-09 | SVB Leerink | Market Perform | Maintains | |
| 2020-11-02 | Mizuho | Neutral | Maintains | |
| 2020-10-29 | BMO Capital | Outperform | Maintains | |
| 2020-10-29 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-10-29 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-29 | B of A Securities | Buy | Maintains | |
| 2020-10-29 | SVB Leerink | Market Perform | Maintains | |
| 2020-10-28 | UBS | Neutral | Initiate | |
| 2020-10-27 | Credit Suisse | Outperform | Maintains | |
| 2020-10-26 | Raymond James | Market Perform | Outperform | Upgrade |
| 2020-10-13 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-12 | Truist Securities | Buy | Hold | Downgrade |
| 2020-10-09 | Truist Securities | Buy | Hold | Downgrade |
| 2020-10-09 | Bernstein | Outperform | Market Perform | Downgrade |
| 2020-10-06 | Oppenheimer | Outperform | Maintains | |
| 2020-07-30 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-07-29 | Piper Sandler | Overweight | Maintains | |
| 2020-07-29 | JP Morgan | Neutral | Maintains | |
| 2020-07-29 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-29 | Cantor Fitzgerald | Overweight | Maintains | |
| 2020-07-29 | Jefferies | Buy | Maintains | |
| 2020-07-29 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-29 | Barclays | Equal-Weight | Maintains | |
| 2020-07-20 | Credit Suisse | Outperform | Maintains | |
| 2020-07-15 | Morgan Stanley | Overweight | Maintains | |
| 2020-06-18 | JP Morgan | Neutral | Maintains | |
| 2020-06-02 | SVB Leerink | Market Perform | Maintains | |
| 2020-05-04 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-05-01 | CFRA | Buy | Maintains | |
| 2020-05-01 | B of A Securities | Buy | Reiterate | |
| 2020-05-01 | Oppenheimer | Outperform | Maintains | |
| 2020-05-01 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-05-01 | SVB Leerink | Market Perform | Maintains | |
| 2020-05-01 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-27 | Oppenheimer | Outperform | Maintains | |
| 2020-04-15 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-30 | Raymond James | Market Perform | Outperform | Upgrade |
| 2020-03-26 | Oppenheimer | Outperform | Maintains | |
| 2020-03-13 | CFRA | Hold | Buy | Upgrade |
| 2020-03-05 | B of A Securities | Neutral | Buy | Upgrade |
| 2020-02-03 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-01-31 | Baird | Neutral | Underperform | Downgrade |
| 2020-01-31 | CFRA | Hold | Maintains | |
| 2020-01-23 | Citigroup | Buy | Maintains | |
| 2020-01-22 | UBS | Neutral | Maintains | |
| 2020-01-21 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2020-01-17 | Morgan Stanley | Overweight | Maintains | |
| 2020-01-09 | BMO Capital | Outperform | Maintains | |
| 2019-12-24 | Raymond James | Market Perform | Initiate | |
| 2019-12-20 | Cowen & Co. | Outperform | Maintains | |
| 2019-12-16 | Goldman Sachs | Buy | Maintains | |
| 2019-12-09 | Argus Research | Buy | Maintains | |
| 2019-11-12 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2019-11-05 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2019-09-05 | Cantor Fitzgerald | Neutral | Reiterate | |
| 2019-08-29 | JP Morgan | Neutral | Maintains | |
| 2019-08-27 | BMO Capital | Outperform | Maintains | |
| 2019-08-27 | RBC Capital | Sector Perform | Maintains | |
| 2019-08-19 | Mizuho | Buy | Neutral | Downgrade |
| 2019-08-16 | Credit Suisse | Outperform | Reiterate | |
| 2019-08-13 | Oppenheimer | Outperform | Maintains | |
| 2019-08-12 | Wells Fargo | Market Perform | Maintains | |
| 2019-07-15 | Morgan Stanley | Overweight | Maintains | |
| 2019-05-23 | Citigroup | Neutral | Buy | Upgrade |
| 2019-05-21 | Credit Suisse | Outperform | Initiate | |
| 2019-03-15 | BMO Capital | Outperform | Initiate | |
| 2019-01-28 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2019-01-04 | Citigroup | Neutral | Neutral | Maintains |
| 2018-12-19 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-11-01 | Citigroup | Neutral | Neutral | Maintains |
| 2018-10-31 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-01 | Cantor Fitzgerald | Neutral | Initiate | |
| 2018-07-30 | Baird | Neutral | Neutral | Maintains |
| 2018-07-30 | Citigroup | Neutral | Neutral | Maintains |
| 2018-07-27 | Jefferies | Buy | Buy | Maintains |
| 2018-07-27 | JP Morgan | Neutral | Neutral | Maintains |
| 2018-07-27 | PiperJaffray | Overweight | Overweight | Maintains |
| 2018-07-13 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-25 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-02-05 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2018-02-02 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-02-02 | PiperJaffray | Overweight | Overweight | Maintains |
| 2018-02-02 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-02-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-24 | JP Morgan | Neutral | Neutral | Maintains |
| 2018-01-23 | Argus | Hold | Buy | Upgrade |
| 2017-11-01 | Argus | Buy | Hold | Downgrade |
| 2017-10-26 | BMO Capital | Market Perform | Maintains | |
| 2017-10-26 | Morgan Stanley | Overweight | Maintains | |
| 2017-10-13 | Barclays | Equal-Weight | Maintains | |
| 2017-10-06 | Morgan Stanley | Overweight | Maintains | |
| 2017-09-29 | Credit Suisse | Outperform | Maintains | |
| 2017-09-15 | RBC Capital | Sector Perform | Initiate | |
| 2017-07-27 | Argus | Buy | Maintains | |
| 2017-07-26 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2017-07-26 | UBS | Neutral | Maintains | |
| 2017-07-10 | Morgan Stanley | Overweight | Maintains | |
| 2017-06-23 | Deutsche Bank | Hold | Initiate | |
| 2017-04-05 | Jefferies | Buy | Hold | Downgrade |
| 2017-03-09 | UBS | Neutral | Initiate | |
| 2017-02-01 | Bank of America | Neutral | Buy | Upgrade |
| 2016-12-13 | Oppenheimer | Outperform | Initiate | |
| 2016-11-08 | Mizuho | Buy | Initiate | |
| 2016-09-28 | Citigroup | Neutral | Maintains | |
| 2016-08-26 | Gabelli & Co. | Hold | Initiate | |
| 2016-07-29 | Citigroup | Neutral | Maintains | |
| 2016-07-28 | Morgan Stanley | Overweight | Maintains | |
| 2016-07-28 | Jefferies | Buy | Maintains | |
| 2016-06-29 | Bernstein | Market Perform | Initiate | |
| 2016-04-05 | BMO Capital | Outperform | Initiate | |
| 2016-02-25 | Citigroup | Neutral | Initiate | |
| 2016-02-08 | Argus | Buy | Maintains | |
| 2016-02-05 | Leerink Swann | Market Perform | Initiate | |
| 2016-01-29 | Credit Suisse | Outperform | Maintains | |
| 2016-01-20 | Credit Suisse | Outperform | Initiate | |
| 2016-01-07 | BTIG Research | Sell | Initiate | |
| 2015-12-18 | Atlantic Equities | Overweight | Initiate | |
| 2015-12-15 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-12-14 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-09-22 | Nomura | Buy | Maintains | |
| 2015-09-07 | UBS | Neutral | Buy | Upgrade |
| 2015-07-31 | Barclays | Equal-Weight | Maintains | |
| 2015-07-09 | UBS | Buy | Neutral | Downgrade |
| 2015-04-22 | Nomura | Buy | Maintains | |
| 2015-04-22 | Jefferies | Buy | Maintains | |
| 2015-01-06 | Barclays | Equal-Weight | Initiate | |
| 2015-01-05 | Morgan Stanley | Overweight | Equal-weight | Downgrade |
| 2014-10-29 | Citigroup | Buy | Maintains | |
| 2014-10-29 | Nomura | Neutral | Buy | Upgrade |
| 2014-10-29 | Credit Suisse | Neutral | Maintains | |
| 2014-10-28 | Jefferies | Buy | Maintains | |
| 2014-10-28 | Nomura | Neutral | Maintains | |
| 2014-07-30 | Deutsche Bank | Buy | Maintains | |
| 2014-07-30 | Citigroup | Buy | Maintains | |
| 2014-07-30 | Nomura | Neutral | Maintains | |
| 2014-07-30 | Credit Suisse | Neutral | Maintains | |
| 2014-07-18 | Deutsche Bank | Buy | Maintains | |
| 2014-04-23 | Deutsche Bank | Buy | Maintains | |
| 2014-04-23 | Nomura | Neutral | Maintains | |
| 2014-03-28 | Jefferies | Buy | Maintains | |
| 2014-03-27 | Morgan Stanley | Overweight | Initiate | |
| 2014-03-18 | Citigroup | Buy | Maintains | |
| 2014-01-14 | Nomura | Neutral | Maintains | |
| 2014-01-08 | Nomura | Neutral | Initiate | |
| 2013-12-06 | Citigroup | Buy | Maintains | |
| 2013-11-20 | Deutsche Bank | Buy | Maintains | |
| 2013-11-19 | Citigroup | Buy | Maintains | |
| 2013-10-23 | Jefferies | Buy | Maintains | |
| 2013-08-26 | BMO Capital | Market Perform | Maintains | |
| 2013-08-26 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2013-08-26 | Jefferies | Buy | Maintains | |
| 2013-05-01 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2013-04-24 | Jefferies | Buy | Maintains | |
| 2013-04-24 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2013-04-19 | Citigroup | Buy | Maintains | |
| 2013-04-12 | UBS | Buy | Maintains | |
| 2013-04-04 | Credit Suisse | Neutral | Maintains | |
| 2013-03-04 | Credit Suisse | Neutral | Maintains | |
| 2013-02-25 | PiperJaffray | Overweight | Maintains | |
| 2013-02-25 | Bank of America | Neutral | Maintains | |
| 2013-02-11 | William Blair | Outperform | Market Perform | Downgrade |
| 2013-01-25 | Argus | Hold | Buy | Upgrade |
| 2013-01-24 | UBS | Buy | Maintains | |
| 2013-01-22 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2012-11-09 | Guggenheim | Neutral | Initiate | |
| 2012-10-24 | Oppenheimer | Perform | Maintains | |
| 2012-10-24 | Jefferies | Buy | Maintains | |
| 2012-10-24 | BMO Capital | Market Perform | Maintains | |
| 2012-10-22 | Deutsche Bank | Hold | Buy | Upgrade |
| 2012-10-15 | Barclays | Equal-Weight | Maintains | |
| 2012-09-27 | Brean Capital | Buy | Initiate | |
| 2012-09-12 | Baird | Outperform | Neutral | Downgrade |
| 2012-09-10 | UBS | Neutral | Buy | Upgrade |
| 2012-07-27 | BMO Capital | Market Perform | Maintains | |
| 2012-07-27 | Jefferies | Buy | Maintains | |
| 2012-07-27 | Deutsche Bank | Hold | Maintains | |
| 2012-07-27 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2012-07-25 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2012-07-18 | Jefferies | Buy | Maintains | |
| 2012-04-26 | UBS | Neutral | Maintains | |
| 2012-04-25 | Goldman Sachs | Neutral | Maintains | |
| 2012-04-25 | Citigroup | Buy | Maintains | |
| 2012-02-10 | Morgan Stanley | Equal-Weight | Initiate | |
| 2012-02-09 | UBS | Neutral | Maintains | |
| 2025-02-06 | B of A Securities | Underperform | Underperform | Maintains |
| 2025-06-24 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-04-22 | Cantor Fitzgerald | Overweight | Initiate | |
| 2025-07-23 | B of A Securities | Underperform | Underperform | Maintains |
| 2024-08-07 | TD Cowen | Buy | Buy | Maintains |
| 2024-08-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-07 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-08-07 | Deutsche Bank | Hold | Hold | Reiterate |
| 2024-08-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-08-07 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2025-03-05 | B of A Securities | Underperform | Underperform | Maintains |
| 2025-01-10 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-08 | Truist Securities | Hold | Hold | Maintains |
| 2025-01-02 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-10-31 | UBS | Neutral | Neutral | Maintains |
| 2024-12-10 | B of A Securities | Underperform | Reiterate | |
| 2025-01-28 | Citigroup | Neutral | Neutral | Maintains |
| 2024-11-27 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-10 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-09-27 | Cantor Fitzgerald | Overweight | Initiate | |
| 2024-09-26 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-09-25 | Baird | Underperform | Underperform | Reiterate |
| 2025-04-14 | UBS | Neutral | Neutral | Maintains |
| 2024-10-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-21 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-17 | Bernstein | Outperform | Initiate | |
| 2024-10-14 | Truist Securities | Buy | Hold | Downgrade |
| 2024-10-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-15 | Wolfe Research | Peer Perform | Initiate | |
| 2024-11-14 | Citigroup | Neutral | Initiate | |
| 2024-11-12 | Jefferies | Buy | Buy | Maintains |
| 2025-05-02 | UBS | Neutral | Neutral | Maintains |
| 2025-05-02 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-01-24 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-04-09 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-16 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-08-06 | UBS | Neutral | Neutral | Maintains |
| 2025-08-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-07 | Mizuho | Neutral | Neutral | Maintains |
| 2025-06-27 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-07-22 | Citigroup | Neutral | Neutral | Maintains |
| 2025-07-21 | UBS | Neutral | Neutral | Maintains |
| 2025-08-06 | Citigroup | Neutral | Neutral | Maintains |
| 2025-08-25 | Piper Sandler | Overweight | Overweight | Maintains |
